Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akram Khan

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
The Journal of Infectious Diseases|April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsJennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2024
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational studyNathaniel M Lewis, Elizabeth J Harker, Lauren B Grant, et al.
JAMA Network Open|April 4, 2024
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsDiya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
JAMA|November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease SeverityMark W Tenforde, Wesley H Self, Katherine Adams, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational StudyAdam S Lauring, Mark W Tenforde, James D Chappell, et al.
BMJ (Clinical Research Ed.)|March 10, 2022
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational studyAdam S Lauring, Mark W Tenforde, James D Chappell, et al.
MMWR. Morbidity and Mortality Weekly Report|March 24, 2022
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022Mark W Tenforde, Wesley H Self, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2021
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United StatesMark W Tenforde, Manish M Patel, Adit A Ginde, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
The Journal of Infectious Diseases|April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsJennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2024
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational studyNathaniel M Lewis, Elizabeth J Harker, Lauren B Grant, et al.
JAMA Network Open|April 4, 2024
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsDiya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
JAMA|November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease SeverityMark W Tenforde, Wesley H Self, Katherine Adams, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational StudyAdam S Lauring, Mark W Tenforde, James D Chappell, et al.
BMJ (Clinical Research Ed.)|March 10, 2022
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational studyAdam S Lauring, Mark W Tenforde, James D Chappell, et al.
MMWR. Morbidity and Mortality Weekly Report|March 24, 2022
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022Mark W Tenforde, Wesley H Self, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2021
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United StatesMark W Tenforde, Manish M Patel, Adit A Ginde, et al.
Pageof 26